ReviewInternational journal of molecular sciences2022

Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets.

Nicola Antonio di Meo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.